Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134749) titled 'A Prospective, Multicenter, Single-Arm Study Evaluating the Efficacy and Safety of Golidocitinib Monotherapy in Patients with Relapsed or Refractory T-Cell Large Granular Lymphocytic Leukemia' on Oct. 20.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: The First Affiliated Hospital, School of Medicine, Zhejiang University

Condition: LGLL

Recruitment Status: Not Recruiting

Phase: 2

Date of First Enrollment: 2026-11-01

Target Sample Size: Trial group:22;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=341476

Disclaimer: Curat...